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Abstract: Massive hemoptysis in patients with advanced thoracic
malignancies can be difficult to manage. Frequently, the bleeding
source is not amenable to either bronchial artery embolization or
surgical resection. Isolation of the bleeding source by endobronchial
tamponade is an alternative management option. This is commonly
achieved by the use of double-lumen endotracheal tubes or the
placement of endobronchial balloons. Although effective, these
approaches are not permanent solutions and may require prolonged
intubation. We describe here an alternative, novel approach to
endobronchial tamponade that does not require prolonged mechan-
ical ventilation. We present a case in which massive hemoptysis
from a left lower lobe cavitary lung cancer was successfully tam-
ponaded and ultimately stopped by the placement of 2 covered
self-expanding bronchial stents, allowing the patient to be extubated
and to undergo further palliative therapy. No recurrent episodes of
hemoptysis occurred throughout the patient’s lifetime.
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Massive hemorrhage from lung cancer may lead to ex-sanguination and asphyxiation. Management includes
localization of the bleeding source with subsequent vascular
embolization1or surgical resection. To protect the contralat-
eral lung, patients may be selectively intubated or ventilated
with a double-lumen endotracheal tube, but these measures
offer only temporary relief. Endobronchial stent placement
with isolation of the bleeding site, while not commonly used
for this indication, offers more permanent protection of the
uninvolved lung without the need for prolonged mechanical
ventilation. We present a case in which emergent deployment
of self-expanding airway stents produced a successful tam-
ponade of massive hemorrhage from a lung cancer, allowing
time for follow-up palliative therapy.
CASE PRESENTATION
A 72-year-old female was diagnosed with metastatic
nonsmall cell lung cancer 17 months prior. The primary
cancer was located in the left lower lobe (LLL) with metas-
tasis to the contralateral lung. Her past medical history was
only remarkable for moderate chronic obstructive pulmonary
disease with a forced expiratory volume in 1 second of 60%
of predicted. Prior treatments had included Carboplatin and
Taxol, Erlotinib and Pemetrexed. She presented with several
weeks of increasing blood tinged sputum, progressing to
frank hemoptysis, dyspnea and fatigue. Initial evaluation
revealed tachypnea, tachycardia, and severe anemia [hemo-
globin drop from baseline 10 g/dl to 5.8 {Hct 19.8%}]. There
was no evidence of coagulopathy. A computed tomography
scan revealed progression of a LLL cavitary lesion. A diag-
nostic bronchoscopy revealed continuous blood welling up
from the LLL orifice. Urgent bronchial and pulmonary arte-
riography did not reveal feeding vessels amenable to embo-
lization. Surgical resection was not thought to be a viable
option based on the large size of the mass, the advanced
metastatic disease and borderline pulmonary function. Be-
cause of ongoing significant bleeding, she was taken for
therapeutic bronchoscopy. Two covered self-expanding air-
way stents were deployed under direct visualization. First, a
Polyflex 8 mm  2 cm stent was deployed in the LLL
bronchus with deliberate expansion against LLL segmental
branches. This yielded transient cessation of bleeding and
provided time to visualize the distal LLL. When the hemor-
rhage became brisk again, a covered nitinol Ultraflex 14 mm
6 cm stent was deployed bridging the proximal left main-stem
bronchus across the LLL opening into the left upper lobe
bronchus, effectively blocking the bleeding site (Figure 1A).
The LLL stent was not removed since it provided reduction in
the intensity of the hemorrhage. Bleeding into the central
airway stopped after this intervention, although fresh blood
could be seen pooling behind the semiopaque stent covering
(Figure 1B). The patient was successfully extubated after-
ward, with resolution of hemoptysis. After initiation of
palliative radiotherapy, she remained stable without further
significant bleeding into the central airways and without
respiratory difficulties in the final 4 months of her life.
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DISCUSSION
Massive hemoptysis from nontraumatic causes has a
high risk of mortality. Common airway interventions include
selective main-stem bronchial intubation or surgical resec-
tion; there are occasional reports of successful tamponade by
airway balloons deployed by bronchoscopy.2 A major disad-
vantage of these approaches is the potential need for pro-
longed endotracheal intubation. This is particularly a concern
with bleeding sources that are unlikely to resolve spontane-
ously, such as hemorrhage from a cavitary cancer. In this case
rapid extubation was achieved after successful tamponade of
the bleeding utilizing covered stents. Endovascular stenting
for the management of pulmonary hemorrhage due to vascu-
lar-bronchial fistulas has been reported.3,4 Airway stenting is
usually performed for the primary purpose of maintaining
airway patency at areas of stenosis, either malignant or
benign. Covered airway stents may also be used to cover over
pathologic openings such as in tracheo-bronchial-esophageal
fistulas. Others have reported that airway stents can occasion-
ally cause massive hemoptysis (through mucosal damage or
erosion into major vessels).5 A thorough Pubmed search
(http://www.ncbi.nlm.nih.gov/sites/entrez) with the following
search parameters: (“endobronchial stent” OR “airway stent,”)
AND (hemoptysis OR bleeding OR hemorrhage) indicates
that this is the first report of the use of self-expanding airway
stents to treat a source of pulmonary hemorrhage. This
treatment was achieved by both tamponade and the isolation
of the bleeding source, so that the proximal large airways
were protected. Possible complications of this approach in-
clude the typical side effects of airway stent deployment as
well as an increased risk for postobstructive pneumonia or
cavity infection in the walled-off part of the lung. In this case,
stent removal would be an easy intervention. No complica-
tions were observed in this patient.
CONCLUSION
Selective airway stenting with the goal of tamponade
and isolation of a pulmonary bleeding source is a novel
approach for the management of massive hemoptysis from
lung cancer. This approach may be considered in selected
patients when interventional vascular embolization and sur-
gical repair are not immediate options.
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FIGURE 1. (A) A three-dimensional reconstruction reveals
the position of the 60  14 mm covered ultraflex stent
which was placed into the left mainstem and the left upper
lobe bronchus (thick white arrow). The left lower lobe bron-
chus is effectively occluded by the stent (white arrow). (B)
After placement of a 60  14 mm ultraflex wall stent,
bloody secretions are pooling (arrow) behind the covered
portion of the stent in the left lower lobe bronchus, but do
not spill over into the left mainstem bronchus.
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